Information Journal Paper
APA:
CopyLIU, Y.. (2015). COMBINED CDKN1A/ TP53 MUTATION IN BLADDER CANCER IS A THERAPEUTIC TARGET. MOLECULAR CANCER THERAPEUTICS, 14(1), 174-182. SID. https://sid.ir/paper/713149/en
Vancouver:
CopyLIU Y.. COMBINED CDKN1A/ TP53 MUTATION IN BLADDER CANCER IS A THERAPEUTIC TARGET. MOLECULAR CANCER THERAPEUTICS[Internet]. 2015;14(1):174-182. Available from: https://sid.ir/paper/713149/en
IEEE:
CopyY. LIU, “COMBINED CDKN1A/ TP53 MUTATION IN BLADDER CANCER IS A THERAPEUTIC TARGET,” MOLECULAR CANCER THERAPEUTICS, vol. 14, no. 1, pp. 174–182, 2015, [Online]. Available: https://sid.ir/paper/713149/en